Insulin and bone health in young adults: The mediator role of lean mass.

Torres-Costoso, Ana; Pozuelo-Carrascosa, Diana P; Álvarez-Bueno, Celia; Ferri-Morales, Asunción; Miota Ibarra, Jose; Notario-Pacheco, Blanca; Martínez-Vizcaíno, Vicente · PLoS One · 2017

cross_sectional · Level IV

Where this comes from

Abstract

The positive relationship between lean mass (LM) and bone health is well known, but a positive association between insulin and LM has also been described. Insulin has some anabolic properties on bone through the stimulation of osteoblast differentiation, yet the role of LM as a confounder or mediator in this relationship remains uncertain. To examine whether the association between insulin levels and bone health is mediated by LM. A cross-sectional study was conducted at the Castilla La Mancha University (Spain) involving 466 young adults (113 young men; 19.5±2.3 years). LM and total-body bone mineral content (BMC) were measured by dual energy x-ray absorptiometry, and insulin was measured in fasting serum samples. Young adults with high total LM had higher values of total-body BMC than their peers after controlling for age and sex, this relationship persisted after adjusting for insulin levels (p<0.001). In mediation analyses, insulin levels were positively associated with total-body BMC (b = 0.05; p<0.001) and total LM acted as an intermediate variable, attenuating the association between insulin levels and total-body BMC (b = -31.98; p>0.05) as indicated by Sobel test values for indirect effect (z = 4.43; p<0.001). LM plays an important role in the relationship between insulin levels and bone health, in such a way that while increases in LM have a positive influence on bone health, they are also negatively associated with insulin levels.

Medical subject headings